268 related articles for article (PubMed ID: 24656278)
1. A case of a patient with stage III familial hidradenitis suppurativa treated with 3 courses of infliximab and died of metastatic squamous cell carcinoma.
Scheinfeld N
Dermatol Online J; 2014 Mar; 20(3):. PubMed ID: 24656278
[TBL] [Abstract][Full Text] [Related]
2. Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.
Scheinfeld N
Dermatol Online J; 2013 Apr; 19(4):1. PubMed ID: 24021361
[TBL] [Abstract][Full Text] [Related]
3. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
4. An atlas of the morphological manifestations of hidradenitis suppurativa.
Scheinfeld N
Dermatol Online J; 2014 Apr; 20(4):22373. PubMed ID: 24746309
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma in the setting of chronic hidradenitis suppurativa; report of a patient and update of the literature.
Pena ZG; Sivamani RK; Konia TH; Eisen DB
Dermatol Online J; 2015 Apr; 21(4):. PubMed ID: 25933081
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.
Groleau PF; Grossberg AL; Gaspari AA
Cutis; 2015 Jun; 95(6):337-42. PubMed ID: 26125210
[TBL] [Abstract][Full Text] [Related]
7. Adalimumab in treatment-resistant hidradenitis suppurativa following recurrence after extensive affected area excision: a review of biologics therapy.
Samycia M; Brassard A
J Cutan Med Surg; 2013 Oct; 17 Suppl 1():S23-32. PubMed ID: 24144253
[TBL] [Abstract][Full Text] [Related]
8. Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents.
Megna M; Bettoli V; Chimenti S; Chiricozzi A; Naldi L; Virgili A; Girolomoni G; Monfrecola G
G Ital Dermatol Venereol; 2015 Dec; 150(6):731-9. PubMed ID: 26513043
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy.
Shanmugam VK; Mulani S; McNish S; Harris S; Buescher T; Amdur R
Int J Dermatol; 2018 Jan; 57(1):62-69. PubMed ID: 29130482
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?
Alhusayen R; Shear NH
Am J Clin Dermatol; 2012 Oct; 13(5):283-91. PubMed ID: 22676319
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
[TBL] [Abstract][Full Text] [Related]
12. Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology.
Melnik BC; Plewig G
Exp Dermatol; 2013 Mar; 22(3):172-7. PubMed ID: 23489419
[TBL] [Abstract][Full Text] [Related]
13. Hidradenitis suppurativa: a review with a focus on treatment data.
Barlev D; Eisen DB; Alikhan A
Skin Therapy Lett; 2015; 20(4):1-8. PubMed ID: 26382710
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hidradenitis suppurativa with biologic medications.
Lee RA; Eisen DB
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S82-8. PubMed ID: 26470624
[TBL] [Abstract][Full Text] [Related]
15. A novel splice site mutation in NCSTN underlies a Japanese family with hidradenitis suppurativa.
Nomura Y; Nomura T; Sakai K; Sasaki K; Ohguchi Y; Mizuno O; Hata H; Aoyagi S; Abe R; Itaya Y; Akiyama M; Shimizu H
Br J Dermatol; 2013 Jan; 168(1):206-9. PubMed ID: 22834455
[TBL] [Abstract][Full Text] [Related]
16. Natural history, presentation, and diagnosis of hidradenitis suppurativa.
Micheletti RG
Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S51-3. PubMed ID: 25188458
[TBL] [Abstract][Full Text] [Related]
17. New onset of articular inflammatory manifestations in patients with hidradenitis suppurativa under treatment with infliximab.
Acquacalda E; Roux CH; Albert C; Breuil V; Passeron T; Euller-Ziegler L
Joint Bone Spine; 2015 Oct; 82(5):362-4. PubMed ID: 25776450
[TBL] [Abstract][Full Text] [Related]
18. Use of biological treatments in patients with hidradenitis suppurativa.
Martin-Ezquerra G; Masferrer E; Masferrer-Niubò M; Ferran M; Sánchez-Regaña M; Collgros H; Bordas X; Notario J; Alsina M; Gil I; Izquierdo N; Aparicio G; Mollet J; Garcia-Patos V; Pujol RM
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):56-60. PubMed ID: 24629001
[TBL] [Abstract][Full Text] [Related]
19. Current and emerging nonsurgical treatment options for hidradenitis suppurativa.
Kerdel FA
Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460
[TBL] [Abstract][Full Text] [Related]
20. The use of photodynamic therapy to treat hidradenitis suppurativa a review and critical analysis.
Scheinfeld N
Dermatol Online J; 2015 Jan; 21(1):. PubMed ID: 25612117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
